Delphinus Medical Technologies, Inc., is a Michigan-based company and a spin-off of the Barbara Ann Karmanos Cancer Institute (KCI). Delphinus has succeeded in building a three-dimensional full-breast ultrasound imaging device using a safe (non-ionizing), comfortable (non-compressing), and reliable (operator independent) patented technology.

The system is not dependent on the skills of the operator and it is fast, with exam times of approximately one minute. Furthermore, SoftVue does not require expensive room preparations making it easy to install in any clinical setting. KCI has transferred all the UST intellectual property to Delphinus Medical Technologies through a worldwide license to commercialize the SoftVue technology.

Delphinus is located in the Michigan LifeScience and Innovation Center at 46701 Commerce Center Drive, in Plymouth, MI.  Delphinus has subcontracted with partners to produce its commercial system.

Delphinus's business model is based on the sales and service of the SoftVue system to hospitals and imaging clinics throughout the United States and the rest of the world. The company plans to use dealer sales organizations in the U.S. for the distribution of the product. In the rest of the world the company will partner with large distributors, or imaging Original Equipment Manufacturers (OEM) looking for an entry into the breast cancer screening market. Delphinus plans to do final assembly and testing of SoftVue through subcontracted manufacturing.